Skip to main content
. Author manuscript; available in PMC: 2023 Dec 27.
Published in final edited form as: Epileptic Disord. 2022 Oct 1;24(5):765–786. doi: 10.1684/epd.2022.1448

Table 4.

Counselling aspects and general considerations for genetic testing in individuals with epilepsy.

Counselling aspects to be considered with affected individual/legal guardian) before genetic testing:
• Explanation of the indication for genetic testing in the individual case
• Explanation of test choice
• Discussion of possible outcomes, e.g., definitive result vs. variant of uncertain significance (VUS) vs. ‘negative’ result
• Explanation of potential positive results
• Discussion of potential effects of results on non-medical issues (e.g., health insurance, social stigma, family dynamics)
• Discussion of the limitations of interpretation
• Outline of expected possibilities for precision medicine
• Discussion of coverage of costs, if relevant
• Discussion of potential next steps if initial results are unrevealing (e.g., for re-analysis or additional testing)
General aspects for the clinician to consider before genetic testing:
• Test selection based on individual phenotype
• Listing of clinical features to the laboratory (e.g., HPO-based list of features)
• Informed consent for genetic testing method(s)
• Consideration of alternatives to clinical testing (e.g., research) if costs are prohibitive.
Counselling aspects to be considered after genetic testing:
• Explanation of results and their impact on diagnosis, surveillance, and prognosis
• Discussion of next steps if results do not provide a genetic diagnosis
• Impact on comorbidities
• Discussion of therapeutic implications
• Impact on psychological wellbeing
• Impact on further family planning and potentially other family members
• Impact on social circumstances
• Discussion of interpretation limits – inclusive positive or negative results and VUS.